Vestibular Migraine (VM) is a common neurological disorder characterized by recurrent episodes of vertigo and migraine symptoms. The pathogenesis of VM is complex and involves multiple genetic and environmental factors. Recent studies have suggested that the pathogenesis of vestibular migraine may be associated with variations in the CACNA1A gene, which is an important gene target for controlling calcium ion channels. Such variations may further affect the functions of the vestibular nervous system, thereby causing a series of vestibular nervous system-related symptoms. This article will summarize the genetic association studies of vestibular migraine, vestibular function studies, and research on how to establish relevant animal models to illustrate the possible association between CACNA1A variations and the pathogenesis of VM, providing new ideas for clarifying the pathogenesis of VM.
References
[1]
Formeister, E.J., Rizk, H.G., Kohn, M.A. and Sharon, J.D. (2018) The Epidemiology of Vestibular Migraine: A Population-Based Survey Study. Otology & Neurotology, 39, 1037-1044. https://doi.org/10.1097/mao.0000000000001900
[2]
Dieterich, M., Obermann, M. and Celebisoy, N. (2016) Vestibular Migraine: The Most Frequent Entity of Episodic Vertigo. Journal of Neurology, 263, 82-89. https://doi.org/10.1007/s00415-015-7905-2
[3]
Neff, B.A., Staab, J.P., Eggers, S.D., Carlson, M.L., Schmitt, W.R., Van Abel, K.M., et al. (2012) Auditory and Vestibular Symptoms and Chronic Subjective Dizziness in Patients with Ménière’s Disease, Vestibular Migraine, and Ménière’s Disease with Concomitant Vestibular Migraine. Otology & Neurotology, 33, 1235-1244. https://doi.org/10.1097/mao.0b013e31825d644a
[4]
Radtke, A., Neuhauser, H., von Brevern, M., Hottenrott, T. and Lempert, T. (2011) Vestibular Migraine—Validity of Clinical Diagnostic Criteria. Cephalalgia, 31, 906-913. https://doi.org/10.1177/0333102411405228
[5]
von Brevern, M. (2004) Acute Migrainous Vertigo: Clinical and Oculographic Findings. Brain, 128, 365-374. https://doi.org/10.1093/brain/awh351
[6]
Skuladottir, A.T., Bjornsdottir, G., Nawaz, M.S., Petersen, H., Rognvaldsson, S., Moore, K.H.S., et al. (2021) A Genome-Wide Meta-Analysis Uncovers Six Sequence Variants Conferring Risk of Vertigo. Communications Biology, 4, Article No. 1148. https://doi.org/10.1038/s42003-021-02673-2
[7]
Szymanowicz, O., Drużdż, A., Słowikowski, B., Pawlak, S., Potocka, E., Goutor, U., et al. (2024) A Review of the CACNA Gene Family: Its Role in Neurological Disorders. Diseases, 12, Article 90. https://doi.org/10.3390/diseases12050090
[8]
(2020) Barany Society Initiative for the Establishment of the International Classification of Vestibular Disorders (ICVD). http://www.jvr-web.org/images/
[9]
Tian, R., Zhang, Y., Pan, Q., Wang, Y., Wen, Q., Fan, X., et al. (2022) Calcitonin Gene-Related Peptide Receptor Antagonist BIBN4096BS Regulates Synaptic Transmission in the Vestibular Nucleus and Improves Vestibular Function via PKC/ERK/CREB Pathway in an Experimental Chronic Migraine Rat Model. The Journal of Headache and Pain, 23, Article No. 35. https://doi.org/10.1186/s10194-022-01403-1
[10]
(2020) The International Classification of Headache Disorders 3rd Edition (β Version). https://beta.ichd-3.org/Last
[11]
Living, E. (1873) On Megrim: Sick Headache and Some Allied Health Disorders: A Contribution to the Pathology of Nerve-Storms. Kessinger Publishing, 129-148.
[12]
Kuritzky, A., Ziegler, D.K. and Hassanein, R. (1981) Vertigo, Motion Sickness and Migraine. Headache: The Journal of Head and Face Pain, 21, 227-231. https://doi.org/10.1111/j.1526-4610.1981.hed2105227.x
[13]
Kayan, A. and Hood, J.D. (1984) Neuro-Otological Manifestations of Migraine. Brain, 107, 1123-1142. https://doi.org/10.1093/brain/107.4.1123
[14]
Leao, A.A.P. (1944) Spreading Depression of Activity in the Cerebral Cortex. Journal of Neurophysiology, 7, 359-390. https://doi.org/10.1152/jn.1944.7.6.359
[15]
Lecrux, C. and Hamel, E. (2011) The Neurovascular Unit in Brain Function and Disease. Acta Physiologica, 203, 47-59. https://doi.org/10.1111/j.1748-1716.2011.02256.x
[16]
Ophoff, R.A., Terwindt, G.M., Vergouwe, M.N., van Eijk, R., Oefner, P.J., Hoffman, S.M.G., et al. (1996) Familial Hemiplegic Migraine and Episodic Ataxia Type-2 Are Caused by Mutations in the Ca2+ Channel Gene Cacnl1a4. Cell, 87, 543-552. https://doi.org/10.1016/s0092-8674(00)81373-2
[17]
Zhou, X., Wang, W., Zhang, S., Wang, X., Tang, Z., Gu, J., et al. (2017) CACNA1B (Cav2.2) Overexpression and Its Association with Clinicopathologic Characteristics and Unfavorable Prognosis in Non-Small Cell Lung Cancer. Disease Markers, 2017, Article ID: 6136401. https://doi.org/10.1155/2017/6136401
[18]
Correa, B.H.M., Moreira, C.R., Hildebrand, M.E. and Vieira, L.B. (2023) The Role of Voltage-Gated Calcium Channels in Basal Ganglia Neurodegenerative Disorders. Current Neuropharmacology, 21, 183-201. https://doi.org/10.2174/1570159x20666220327211156
[19]
Li, W., Zheng, N., Yuan, Q., Xu, K., Yang, F., Gu, L., et al. (2016) NFAT5-Mediated CACNA1C Expression Is Critical for Cardiac Electrophysiological Development and Maturation. Journal of Molecular Medicine, 94, 993-1002. https://doi.org/10.1007/s00109-016-1444-x
[20]
van Loo, K.M.J., Schaub, C., Pernhorst, K., Yaari, Y., Beck, H., Schoch, S., et al. (2012) Transcriptional Regulation of T-Type Calcium Channel CaV3.2: Bi-Directionality by Early Growth Response 1 (Egr1) and Repressor Element 1 (RE-1) Protein-Silencing Transcription Factor (REST). Journal of Biological Chemistry, 287, 15489-15501. https://doi.org/10.1074/jbc.m111.310763
[21]
Jurkat-Rott, K. and Lehmann-Horn, F. (2004) The Impact of Splice Isoforms on Voltage-Gated Calcium Channel Α1 Subunits. The Journal of Physiology, 554, 609-619. https://doi.org/10.1113/jphysiol.2003.052712
[22]
Morton, S.U., Sefton, C.R., Zhang, H., Dai, M., Turner, D.L., Uhler, M.D., et al. (2021) Microrna-mRNA Profile of Skeletal Muscle Differentiation and Relevance to Congenital Myotonic Dystrophy. International Journal of Molecular Sciences, 22, Article 2692. https://doi.org/10.3390/ijms22052692
[23]
Zamponi, G.W., Bourinet, E., Nelson, D., Nargeot, J. and Snutch, T.P. (1997) Crosstalk between G Proteins and Protein Kinase C Mediated by the Calcium Channel α1 Subunit. Nature, 385, 442-446. https://doi.org/10.1038/385442a0
[24]
Lee, A., Scheuer, T. and Catterall, W.A. (2000) Ca2+/Calmodulin-Dependent Facilitation and Inactivation of P/Q-Type Ca2+ Channels. The Journal of Neuroscience, 20, 6830-6838. https://doi.org/10.1523/jneurosci.20-18-06830.2000
[25]
Ishii, M., Kobayashi, S., Ohkura, M., Yamamoto, R., Shimizu, S. and Kiuchi, Y. (2009) Inhibitory Effect of Lomerizine, a Prophylactic Drug for Migraines, on Serotonin-Induced Contraction of the Basilar Artery. Journal of Pharmacological Sciences, 111, 221-225. https://doi.org/10.1254/jphs.09205sc
[26]
Dornhoffer, J.R., Liu, Y.F., Donaldson, L. and Rizk, H.G. (2020) Factors Implicated in Response to Treatment/Prognosis of Vestibular Migraine. European Archives of Oto-Rhino-Laryngology, 278, 57-66. https://doi.org/10.1007/s00405-020-06061-0
[27]
de Vries, B., Frants, R.R., Ferrari, M.D. and van den Maagdenberg, A.M.J.M. (2009) Molecular Genetics of Migraine. Human Genetics, 126, 115-132. https://doi.org/10.1007/s00439-009-0684-z
[28]
Gritz, S.M. and Radcliffe, R.A. (2013) Genetic Effects of ATP1A2 in Familial Hemiplegic Migraine Type II and Animal Models. Human Genomics, 7, Article No. 8. https://doi.org/10.1186/1479-7364-7-8
[29]
Barrett, C.F., Cao, Y. and Tsien, R.W. (2005) Gating Deficiency in a Familial Hemiplegic Migraine Type 1 Mutant P/Q-Type Calcium Channel. Journal of Biological Chemistry, 280, 24064-24071. https://doi.org/10.1074/jbc.m502223200
[30]
Dunlap, K., Luebke, J.I. and Turner, T.J. (1995) Exocytotic Ca2+ Channels in Mammalian Central Neurons. Trends in Neurosciences, 18, 89-98. https://doi.org/10.1016/0166-2236(95)80030-6
[31]
Shi, X., Wang, J., Li, F., Zhang, Y., Qu, W., Dai, C., et al. (2022) Whole-Brain Monosynaptic Outputs and Presynaptic Inputs of Gabaergic Neurons in the Vestibular Nuclei Complex of Mice. Frontiers in Neuroscience, 16, Article 982596. https://doi.org/10.3389/fnins.2022.982596
[32]
Adams, P.J. and Snutch, T.P. (2007) Calcium Channelopathies: Voltage-Gated Calcium Channels. In: Carafoli, E. and Brini, M., Eds., Calcium Signalling and Disease, Springer Netherlands, 215-251. https://doi.org/10.1007/978-1-4020-6191-2_8
[33]
Jones, S.M., Vijayakumar, S., Dow, S.A., Holt, J.C., Jordan, P.M. and Luebke, A.E. (2018) Loss of α-Calcitonin Gene-Related Peptide (αCGRP) Reduces Otolith Activation Timing Dynamics and Impairs Balance. Frontiers in Molecular Neuroscience, 11, Article 289. https://doi.org/10.3389/fnmol.2018.00289
[34]
Hautakangas, H., Winsvold, B.S., Ruotsalainen, S.E., Bjornsdottir, G., Harder, A.V.E., Kogelman, L.J.A., et al. (2022) Genome-Wide Analysis of 102,084 Migraine Cases Identifies 123 Risk Loci and Subtype-Specific Risk Alleles. Nature Genetics, 54, 152-160. https://doi.org/10.1038/s41588-021-00990-0
[35]
de Vries, B., Frants, R.R., Ferrari, M.D. and van den Maagdenberg, A.M.J.M. (2009) Molecular Genetics of Migraine. Human Genetics, 126, 115-132. https://doi.org/10.1007/s00439-009-0684-z
[36]
Russell, M.B. and Olesen, J. (1995) Increased Familial Risk and Evidence of Genetic Factor in Migraine. BMJ, 311, 541-544. https://doi.org/10.1136/bmj.311.7004.541
[37]
Ferrari, M.D., Klever, R.R., Terwindt, G.M., Ayata, C. and van den Maagdenberg, A.M.J.M. (2015) Migraine Pathophysiology: Lessons from Mouse Models and Human Genetics. The Lancet Neurology, 14, 65-80. https://doi.org/10.1016/s1474-4422(14)70220-0
